Acuitas Investments’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$1.08M Buy
2024
Q2
$858K Buy
2024
Q1
$1.04M Buy
2023
Q4
$615K Buy
2023
Q3
$370K Sell
2023
Q2
$462K Buy